Effect of low-dose oral contraceptives on androgenic markers and acne
- 1 November 1999
- journal article
- clinical trial
- Published by Elsevier in Contraception
- Vol. 60 (5) , 255-262
- https://doi.org/10.1016/s0010-7824(99)00093-1
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: A randomized, placebo-controlled trialObstetrics & Gynecology, 1997
- A multirater validation study to assess the reliability of acne lesion countingJournal of the American Academy of Dermatology, 1996
- Modeling Acne in VitroJournal of Investigative Dermatology, 1996
- Classification and comparison of oral contraceptives containing new generation progestogensHuman Reproduction Update, 1995
- A prospective randomized trial comparing finasteride to spironolactone in the treatment of hirsute womenJournal of Clinical Endocrinology & Metabolism, 1995
- Selectivity and minimal androgenicity of norgestimate in monophasic and triphasic oral contraceptivesActa Obstetricia et Gynecologica Scandinavica, 1992
- AN OPEN STUDY OF TRIPHASIL AND DIANE 50 IN THE TREATMENT OF ACNEAustralasian Journal of Dermatology, 1991
- The Treatment of Hyperandrogenism with Oral ContraceptivesSeminars in Reproductive Medicine, 1989
- Cyproterone Acetate Versus Levonorgestrel Combined with Ethinyl Estradiol in the Treatment of Acne: Results of a multicenter study*Acta Obstetricia et Gynecologica Scandinavica, 1986
- THE TREATMENT OF HIRSUTISM WITH A COMBINATION OF DESOGESTREL AND ETHINYL OESTRADIOLClinical Endocrinology, 1985